SCHEMBL5033288

SCHEMBL5033288

CC(=O)OC1(c2ccccc2)OCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.41
NPSR1 Q6W5P4 1/20 0.39
OPRM1 P35372 1/20 0.39
OPRL1 P41146 1/20 0.39
ELANE P08246 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 4/20 0.37
CYP1A2 P05177 1/20 0.37
MAPK1 P28482 1/20 0.36
AKR1C1 Q04828 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 2/20 0.36
KDM4E B2RXH2 1/20 0.34
ESR1 P03372 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
HMGB1 P09429 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11812697 0.80 HSD17B10 (0.41) GAANPSR1OPRM1OPRL1ALDH1A1
SCHEMBL8752796 0.74 MAPT (0.40) GAANPSR1MEN1KMT2AALDH1A1
SCHEMBL8749501 0.72 CYP1A2 (0.31) MEN1KMT2ACYP1A2
SCHEMBL11807841 0.72 ALPG (0.41) GAAALDH1A1CYP1A2HSP90AA1MAPT
SCHEMBL7597192 0.71 GAA (0.40) GAANPSR1OPRM1OPRL1ELANE
SCHEMBL23762899 0.70 AKR1C1 (0.48) GAANPSR1OPRM1OPRL1MEN1
SCHEMBL29222624 0.70 ALDH1A1 (0.47) GAANPSR1ALDH1A1MAPTTSHR
SCHEMBL8990273 0.70 GAA (0.42) GAANPSR1OPRM1OPRL1MEN1
SCHEMBL4105893 0.69 AKR1C1 (0.47) GAANPSR1OPRM1OPRL1MEN1
SCHEMBL14657363 0.69 GAA (0.47) GAANPSR1OPRM1OPRL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1894603-B1 Encapsulation of bulky fragrance molecules TAKASAGO PERFUMERY CO LTD (JP) 2014-11-19 EP claimed
EP-2832441-B1 MICROCAPSULES TAKASAGO PERFUMERY CO LTD (JP) 2019-09-11 EP disclosed
US-9895297-B2 Microcapsules TAKASAGO INTERNATIONAL CORPORATION (JP) 2018-02-20 US disclosed
US-20160206522-A1 MICROCAPSULES TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-07-21 US disclosed
WO-2015016369-A1 MICROCAPSULES TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-02-05 WO disclosed
EP-2832441-A1 Microcapsules Takasago International Corporation (JP) 2015-02-04 EP disclosed
EP-1894603-B1 Encapsulation of bulky fragrance molecules TAKASAGO PERFUMERY CO LTD (JP) 2014-11-19 EP disclosed
EP-1894603-A1 Encapsulation of bulky fragrance molecules Takasago International Corporation (JP) 2008-03-05 EP disclosed
US-6417380-B1 POLYCYCLOALKYL KETONE CONTAINING FLUORESCENT CHROMOPHORE IS ALKYLATED TO POLYCYCLOALKYLIDENE ETHER IN PRESENCE OF ALKALI METAL ALKOXIDE IN POLAR APROTIC SOLVENT APPLIED BIOSYSTEMS, LLC 2002-07-09 US disclosed
US-6124478-A Methods of using 1,2-dioxetanes and kits therefore TROPIX, INC. (US) 2000-09-26 US disclosed
EP-0416038-B1 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED TROPIX INC (US) 1997-03-26 EP disclosed
EP-0582317-A2 Synthesis of 1,2-dioxetanes and intermediates therefor TROPIX, INC. (US) 1994-02-09 EP disclosed
US-5177241-A SYNTHESIS OF 1,2-DIOXETANES AND INTERMEDIATES THEREFOR APPLIED BIOSYSTEMS, LLC 1993-01-05 US disclosed
EP-0416038-A4 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED 1992-02-26 EP disclosed
EP-0416038-A1 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED. TROPIX INC (US) 1991-03-13 EP disclosed
US-4956477-A Synthesis of 1,2-dioxetanes TROPIX, INC. (US) 1990-09-11 US disclosed
EP-0368946-A1 1,2-DIOXETANES. QUEST SYSTEMS INC (US) 1990-05-23 EP disclosed
EP-0368946-A4 1,2-DIOXETANES. QUEST SYSTEMS INC (US) 1990-05-14 EP disclosed
WO-1990000164-A1 NOVEL CHEMILUMINESCENT FUSED POLYCYCLIC RING-CONTAINING 1,2-DIOXETANES AND ASSAYS IN WHICH THEY ARE USED TROPIX, INC. (US) 1990-01-11 WO disclosed
WO-1989006226-A1 SYNTHESIS OF 1,2-DIOXETANES AND INTERMEDIATES THEREFOR QUEST SYSTEMS, INC. (US) 1989-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160206522-A1 MICROCAPSULES MITF, PLIN5, MLEC GAA 130/4885NPSR1 2250/4885OPRM1 3457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.